Quoin Pharmaceuticals (QNRX) Gains from Investment Securities (2021 - 2022)
Quoin Pharmaceuticals (QNRX) posted Gains from Investment Securities of -$77237.0 for Q1 2022, down 100.93% sequentially from $8.3 million in Q4 2021.
Quoin Pharmaceuticals (QNRX) Gains from Investment Securities (2021 - 2022) Analysis & Trends
Quoin Pharmaceuticals has reported Gains from Investment Securities for 2 years, with the latest figure at -$77237.0 in Q1 2022.
- Quarterly Gains from Investment Securities changed N/A year-over-year to -$77237.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was -$77237.0 (changed N/A YoY) and the FY2022 annual result came in at -$77237.0, down 100.6% from the prior year.
- Gains from Investment Securities slipped to -$77237.0 in Q1 2022 per QNRX's latest filing, from $8.3 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $8.3 million in Q4 2021 and troughed at -$146808.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -77,237.00 |
| Mar 31, 2022 | -77,237.00 |
| Dec 31, 2021 | 8.26 Mn |
| Dec 31, 2021 | 8.26 Mn |
| Sep 30, 2021 | -146,808.00 |
| Sep 30, 2021 | -146,808.00 |
| Jun 30, 2021 | 2.22 Mn |
| Jun 30, 2021 | 2.22 Mn |